Hengyi Xu

5PUBLICATIONS
20CO-AUTHORS
Tumour immunologyIndustrial molecular engineering of nucleic acids and proteinsGene expression (incl. microarray and other genome-wide approaches)Neurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 01, 2026
Pervasive enhanced transcription in inflammatory breast cancer tumors and PBMCs impacts RNA splicing and intronic RNAs in plasma.

|Sep 18, 2025
A bacterial PrimPol-reverse transcriptase hybrid protein has a proofreading exonuclease activity that can be transferred to other reverse transcriptases.

Seungjin Kim, Hengyi Xu, Georg Mohr

|Sep 26, 2024
Human cells contain myriad excised linear intron RNAs with links to gene regulation and potential utility as biomarkers.

Jun Yao, Hengyi Xu, Elizabeth A Ferrick-Kiddie

|May 08, 2024
Senataxin deficiency disrupts proteostasis through nucleolar ncRNA-driven protein aggregation.

Xuemei Wen, Hengyi Xu, Phillip R Woolley

|Jul 03, 2023
TGIRT-seq of Inflammatory Breast Cancer Tumor and Blood Samples Reveals Widespread Enhanced Transcription Impacting RNA Splicing and Intronic RNAs in Plasma.

Dennis Wylie, Xiaoping Wang, Jun Yao

Pageof 1

Frequent Collaborators

5 joint publications

Jun Yao

5 joint publications

Alan M Lambowitz

3 joint publications

Elizabeth A Ferrick-Kiddie

2 joint publications

Dennis Wylie